3-D Matrix, Ltd.

Tokyo Stock Exchange 7777.T

3-D Matrix, Ltd. EBIT Margin for the year ending April 30, 2024: -0.54%

3-D Matrix, Ltd. EBIT Margin is -0.54% for the year ending April 30, 2024, a 99.48% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • 3-D Matrix, Ltd. EBIT Margin for the year ending April 30, 2023 was -105.57%, a 16.00% change year over year.
  • 3-D Matrix, Ltd. EBIT Margin for the year ending April 30, 2022 was -125.68%, a 35.98% change year over year.
  • 3-D Matrix, Ltd. EBIT Margin for the year ending April 30, 2021 was -196.31%, a 57.35% change year over year.
  • 3-D Matrix, Ltd. EBIT Margin for the year ending April 30, 2020 was -460.28%, a 40.71% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 7777.T

3-D Matrix, Ltd.

CEO Mr. Jun Okada
IPO Date Oct. 24, 2011
Location Japan
Headquarters Kojimachi HF Building
Employees 106
Sector Materials
Industries
Description

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.

Similar companies

9902.T

NICHIDEN Corporation

USD 18.55

-2.15%

7408.T

JAMCO Corporation

USD 11.84

-0.09%

7774.T

Japan Tissue Engineering Co., Ltd.

USD 3.09

2.94%

7775.T

Daiken Medical Co., Ltd.

USD 3.30

-0.12%

7779.T

CYBERDYNE Inc.

USD 1.20

2.92%

StockViz Staff

February 11, 2025

Any question? Send us an email